board appointment

iDEL Therapeutics appoints Dr. Claudia Ulbrich as Board Chair and secures €9M seed funding led by BiomedVC to advance its novel cancer drug delivery platform.

Orange appoints Fives Group CEO Frédéric Sanchez as new board chairman effective May 2026, succeeding Jacques Aschenbroich under statutory retirement rules.

Orange appoints independent director Frédéric Sanchez as new Chairman effective May 2026, succeeding Jacques Aschenbroich who reaches statutory retirement age.

T. Rowe Price CEO Robert W. Sharps joins Longeviti Neuro Solutions' board, bringing three decades of asset management expertise to support the AI-driven neurotechnology company's growth.

NOV appoints Kennametal CEO Sanjay Chowbey to board effective March 2026, bringing 20+ years manufacturing leadership experience to Audit Committee.

Artemis Gold appoints veteran mining executive George Salamis to board as Blackwater Mine reaches commercial production, strengthening governance during operational ramp-up.

Sotera Health appoints CFO Kenneth Krause from Rollins Inc. to board, strengthening financial expertise as Constantine Mihas resigns due to reduced director positions.

USA Rare Earth appoints former GlobalFoundries CEO Dr. Thomas Caulfield to board following $1.6B government funding and $1.5B private investment securing rare earth supply independence.

ICG plc appoints Jonathon Bond as Independent Non-Executive Director while Stephen Welton and Rosemary Leith retire in July 2026 board refresh.

Tactile Medical ($TCMD) appoints veteran healthcare executive Andrea Pearson to board, strengthening governance with 25+ years of industry scaling expertise.

Vera Therapeutics appoints Christopher Hite, Royalty Pharma EVP, to board as the biotech prepares for atacicept launch in IgA nephropathy treatment.

LayerX Security appoints Rupal Hollenbeck, veteran tech executive from Check Point and Oracle, as Board Chair to strengthen governance amid explosive AI security market growth.

Vallourec completed €6.05M share buyback program in late February 2026, acquiring 309,704 shares at €19.55 average price.

Vallourec repurchased 309,704 shares at €19.55 average price and appointed ArcelorMittal-backed director David Clarke to its board.